abstract |
Present invention provides compound – N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazine-2-yl)carbamoyl)benzofuran-4-iloxy)pyrimidine-2-carboxamide and pharmaceutically acceptable salts thereof, compositions containing them and application thereat the treatment of diseases, disorders or conditions caused by glucokinase. |